Phase 1 Trial of PAN-301-1 (SNS-301) in Cancer Patients

NCT03120832 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sensei Biotherapeutics, Inc.

Collaborators